| 23/09/2022 11:00 | 70duaesigned.pdf | Doc. de eligibilitate (DUAE) | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 70duaesigned.pdf | Romana |
| 25/11/2022 17:54 | 10cereredeparticiparesigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 10cereredeparticiparesigned.pdf | Romana |
| 25/11/2022 17:54 | 20declaratieprivindvalabilitateaoferteisigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 20declaratieprivindvalabilitateaoferteisigned.pdf | Romana |
| 25/11/2022 17:54 | 30garantiedeoferta_2309signedsigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 30garantiedeoferta_2309signedsigned.pdf | Romana |
| 25/11/2022 17:54 | 40licentaafsigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 40licentaafsigned.pdf | Romana |
| 25/11/2022 17:54 | 50propunereatehnicăsigned.pdf | Propunere tehnică | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 50propunereatehnicăsigned.pdf | Romana |
| 25/11/2022 17:54 | 60propunereafinanciarăsigned.pdf | Propunere financiară | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 60propunereafinanciarăsigned.pdf | Romana |
| 25/11/2022 17:54 | 80certificatdeinregistraresigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 80certificatdeinregistraresigned.pdf | Romana |
| 25/11/2022 17:54 | 90extrasdinregistrusigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 90extrasdinregistrusigned.pdf | Romana |
| 25/11/2022 17:54 | 100raportfinanciar2021signed.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 100raportfinanciar2021signed.pdf | Romana |
| 25/11/2022 17:54 | 110listafondatorilorsigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 110listafondatorilorsigned.pdf | Romana |
| 25/11/2022 17:54 | 120certificatsfssigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 120certificatsfssigned.pdf | Romana |
| 25/11/2022 17:54 | 130certificatmaibsigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 130certificatmaibsigned.pdf | Romana |
| 25/11/2022 17:54 | 140declaratietermenrestantsigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | 140declaratietermenrestantsigned.pdf | Romana |
| 25/11/2022 17:54 | declaratieprospecttransesigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | declaratieprospecttransesigned.pdf | Romana |
| 25/11/2022 17:54 | gmpemcuresigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | gmpemcuresigned.pdf | Romana |
| 25/11/2022 17:54 | viropilsigned.pdf | Doc. de calificare | Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg | viropilsigned.pdf | Romana |